Supplement Tied to Stroke Risk; Cheese Recall Is Most Serious; GLP-1 Pioneer Dies

(MedPage Today) — Note that some links may require registration or subscription. Silintan capsules, a dietary supplement marketed for joint and body aches, have been recalled due to the presence of meloxicam, a nonsteroidal anti-inflammatory…
Lexaria’s DehydraTECH shows reduced side effects in GLP-1 drugs
10 Stars Whose Dramatic Transformations Stunned Fans At The 2026 Golden Globes

The 2026 Golden Globes dazzled Hollywood at the Beverly Hilton Hotel in California on January 11, celebrating some of the biggest names in film and television. From award-winning performances to unforgettable red carpet moments, the night had fans and critics talking, but not all the chatter was about fashion. As stars like Jennifer Lawrence, Selena […]
Health Canada approves 1st GLP-1 daily pill. Here’s who can take it

The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement Monday.
What is ‘natural Ozempic’ – and how good is the science?

As slimming jabs explode in popularity, interest is growing in a potential alternative, in the form of a weight-loss supplement sometimes called “natural Ozempic”. It consists of natural oils designed to stimulate production of hormones normally released after eating – one of which is the same hormone mimicked by weight-loss jabs, called GLP-1. There is […]
Rising Public Interest in Weight Loss Medications and Growing Awareness of Their Aesthetic Sequelae: An Infodemiologic Google Trends Analysis and Clinical Diagnostic Patterning

ABSTRACT Background Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained rapid popularity for both medical and consumer-directed weight loss. This growth has been accompanied by increased public discussion regarding facial aesthetic changes, commonly referred to as “Ozempic face,” characterized by volume depletion and cutaneous laxity. Objective To quantify temporal patterns of public search interest in […]
How Ozempic and Wegovy are quietly cutting America’s food bills

Weight-loss drugs like Ozempic and Wegovy are changing how Americans spend money on food. A large Cornell study found households cut grocery spending by over 5% within six months, with even bigger drops at fast-food restaurants. Snack foods and sweets saw the steepest declines, while only a few categories like yogurt and fruit rose slightly. The effects linger for at least a year among continued users.
Does Ozempic need to be taken forever once started? UK surgeon explains the effects of stopping GLP-1 drugs

According to Dr Rajan, GLP-1 drugs such as Ozempic is not designed for long-term weight loss, which requires a comprehensive approach.
Skin Reactions Uncommon but Vary by GLP-1 RAs

Cutaneous adverse events associated with GLP-1 receptor agonists are uncommon but vary by agent, a study of FDA data shows. Medscape Medical News
The humble egg: A natural, affordable ally in the battle against weight regain

(NaturalNews) A leading nutrition scientist proposes eggs as a key dietary tool for people stopping GLP-1 agonist drugs (like Ozempic) to help prevent the signi…